The following example of utility illustrates such a probe-based assay to detect the most common KRAS mutation type (G12D), which accounts for ∼32.5% of all KRAS mutations (42), from FFPE samples of colorectal cancer patients. This evidence concerns the gene KRAS and colorectal cancer.